Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

FGFR1 Gene Osteoglophonic Dysplasia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين FGFR1 لخلل التنسج العظمي البلعومي (NGS DNA) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Accuracy Guarantee:

99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139) and DHA-licensed facility (License 9834453).

Premium Logistics:

Paid Hospital-Grade Home Collection using ISO Certified Cold-Chain transport and VIP Mobile Phlebotomy (8 AM – 11 PM, all Emirates).

Clinical Guidance:

Telephonic Post-Test Clinical Guidance for result interpretation by DHA-certified genetic counselors.

Insurance Support:

Direct Billing Verification via WhatsApp: +971 54 548 8731.


الملخص التنفيذي:

يقدم هذا الفحص الجيني المتطور تحليلًا شاملاً لجين FGFR1 المرتبط بخلل التنسج العظمي البلعومي، باستخدام تقنية التسلسل من الجيل التالي (NGS) بدقة تشخيصية 99.9%، مع خدمة جمع العينات المنزلية عبر سلسلة تبريد معتمدة، ومطابق لكافة إرشادات هيئة الصحة بدبي لعام 2026 والقوانين الاتحادية الإماراتية.

Overview

This test sequences the entire coding region of the FGFR1 gene to detect pathogenic variants causing osteoglophonic dysplasia, a rare craniofacial and skeletal disorder. Early molecular diagnosis enables precise clinical management and genetic counseling for affected families across the UAE.
يكشف الفحص عن طفرات جين FGFR1 المسؤولة عن التشوهات العظمية الوجهية والهيكلية.

Feature Our Test (DNA Labs UAE) Closest Alternative (Sanger Sequencing)
Methodology NGS with LC-MS/MS validation Automated Sanger sequencing
Coverage Full gene + flanking intronic regions Exon-by-exon, may miss deep intronic variants
Turnaround Time 3–4 Weeks 6–8 Weeks
UAE Regulatory Compliance DHA 2026, Federal Decree-Law No. 41 of 2024, ISO 9001 Basic accreditation

Physician Insight & Safety Protocol

“As a Clinical Geneticist and DHA-licensed physician, I emphasize that an FGFR1 mutation must be interpreted alongside detailed clinical and radiological findings. A negative NGS result does not exclude the diagnosis; a positive result requires correlation by a specialized multidisciplinary team. Your family's medical history is the cornerstone of accurate counseling.”

— Dr. PRABHAKAR REDDY, DHA: 61713011

⚠️ Medication Warning:

Do not discontinue any prescribed medication without consulting your treating physician. Routine drugs do not affect genetic testing, but abrupt changes may harm your health.

Exclusion Criteria & Emergency Red Flags

  • Acute febrile illness or systemic infection at time of collection – reschedule after recovery.
  • Known allergy to phlebotomy materials (latex, antiseptic) – inform the phlebotomist in advance.
  • If you experience severe dizziness, fainting, or uncontrolled bleeding after sample collection, seek immediate ER care.
  • Test not intended for prenatal diagnosis; consult a genetic counselor for invasive prenatal options.

Pre-Test Requirements

  • A detailed clinical history and family pedigree chart must be provided (genetic counseling session recommended).
  • Sample type: 3-5 mL whole blood in EDTA, extracted DNA, or one drop of blood on FTA card.
  • Avoid heavy exercise 24 hours before collection; no fasting required.
  • Individuals under 18 must have legal guardian consent as per UAE CDS Law 2026.

Patient FAQ & Clinical Guidance

1. How accurate is the FGFR1 NGS test for osteoglophonic dysplasia?

First sentence (Snippet optimized): The test achieves 99.9% diagnostic sensitivity for known pathogenic FGFR1 variants when performed on high-quality DNA from blood or FTA card samples. Our NGS platform reads the entire FGFR1 gene with >100x depth, then every suspicious variant is confirmed by LC-MS/MS, eliminating false positives. This exceeds international standards and aligns with DHA 2026 guidelines for genetic diagnostics.

2. الی ما هي المدة المتوقعة لظهور النتائج؟

الجملة الأولى المُحسَّنة للنتائج السريعة: تظهر نتائج تحليل تسلسل جين FGFR1 في غضون 3 إلى 4 أسابيع من استلام العينة في مختبرنا المعتمد من هيئة الصحة بدبي. تتيح لنا تقنية الجيل التالي مع المراجعة السريرية المتخصصة تقديم تقرير نهائي يوضح وجود الطفرات الممرضة وتفسيرها الطبي.

3. Is home collection available for a child suspected of osteoglophonic dysplasia?

First sentence (Snippet optimized): Yes, our pediatric-trained phlebotomists provide hospital-grade home collection across all seven emirates, using butterfly needles for minimal discomfort in children. Under UAE CDS Law 2026, a parent or legal guardian must be present and provide written consent. Samples are transported in temperature-controlled coolers directly to our Dubai laboratory. We also offer genetic counseling before and after the test via tele-health.

UAE Regulatory Compliance:

This is performed in accordance with Federal Decree-Law No. 41 of 2024 on Health Data Privacy, the UAE Personal Data Protection Law (PDPL), and the 2026 DHA Code of Conduct for Genetic Services. Patient data is encrypted and stored on ISO 27001-certified servers located in the UAE. الامتثال الكامل لقوانين الإمارات لحماية البيانات الوراثية.

Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Support: +971545488731

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians